Atypical HUS Therapeutic Drug Pipeline in 2018
Drug Discovery and Market Factors within the Atypical HUS Arena E: info@aHUSallianceAction.org The aHUS Alliance is an international group of…
aHUS and TMA Study Centers
aHUS and TMA Study Centers An International List Compiled by the aHUS Alliance Atypical HUS is difficult…
Website for aHUS that connects informs and collaborates
This version of the aHUS alliance website has been running for nearly 2 years ( there was a temporary one which…
Someone has to be the first
Twenty years ago today, in 1998, an article appeared in Kidney International , the Journal of the International Society of Nephrology…
ESKD 2018 Global Health Summit in UAE
Mr Kamal D. Shah, founder of Atypical HUS India and co-founder of India’s largest network of dialysis clinics, was…
Dr Ralf Reski on Moss-Made Biopharmaceuticals: aHUS Alliance Interview
The aHUS Alliance recently conducted an interview with Dr Ralf Reski, a professor and researcher in the field of…
Atypical HUS: Symptoms can be Perplexing
People living with the rare disease atypical hemolytic uremic syndrome (atypical HUS or aHUS) face many challenges, including the…
ERKNET and aHUS
An anniversary passed just over a week or so on Rare Disease Day, with very little awareness in the aHUS /Renal…
aHUS Rare Disease Day 2018 Cohort – Report 2
In the first report on the aHUS Rare Diseases Day 2018 Cohort, ( click here) it was found that the participants…
- Go to the previous page
- 1
- …
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- …
- 51
- Go to the next page